2.14 USD
▲+0.06+3.88%
盘后 2.10 +1.94%
2026-08-03
市值
$32.09M
市盈率
—
EPS
-2.00
股息率
—
52 周区间
1.22 – 7.92
成交量
44.98K
Beta
0.03
目标价
9.50
52W 低 1.2252W 高 7.92
价格走势
公司简介
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson’s and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it ...